What is the current approach for optimizing Percutaneous Coronary Intervention (PCI) using Intravascular Ultrasound (IVUS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Approach for Optimizing PCI Using IVUS

IVUS guidance during PCI significantly improves clinical outcomes by enabling optimal stent deployment, reducing stent thrombosis, and minimizing restenosis compared to angiography-guided procedures. 1

Pre-Intervention Assessment

  • IVUS provides critical pre-intervention assessment of plaque composition, lesion characteristics, and identification of optimal reference segments and landing zones for stent placement 1
  • Pre-intervention IVUS helps select optimal stent length and diameter, preventing systematic undersizing of stents 1
  • IVUS should be performed after administration of intracoronary nitroglycerine, beginning at least 20mm distal to the area of interest and ending at the vessel ostium 1
  • IVUS helps identify vulnerable plaques at risk of future rupture, even if not anatomically or physiologically significant, which may guide intensification of medical therapy 1

Lesion Preparation and Stent Deployment

  • IVUS improves detection, localization, and characterization of coronary calcification (thickness, angle, length) to guide appropriate adjunctive therapies (angioplasty, atherectomy, lithotripsy) 1
  • IVUS-based scoring systems help identify calcified stenoses at risk for stent under-expansion that may require adjunctive modification before stent implantation 1
  • Stent lengths should be selected to cover from the most normal distal segment to the most normal proximal segment 1
  • Avoid stenting into reference segments with restricted lumen areas and plaque burden >50% or segments with large lipid plaque or significant calcification 1
  • For tapering vessels (like left main and bifurcations), IVUS helps in selecting appropriate stent sizes and determining when an upfront 2-stent bifurcation strategy is preferable 1, 2

IVUS Optimization Criteria from ULTIMATE Trial

  • Minimum lumen area (MLA) in the IVUS-stented segment >5.0 mm² or 90% of the MLA at the distal reference segments 1
  • <50% plaque burden within 5mm proximal or distal to the stent edge 1
  • No edge dissection involving the media with a length >3mm 1

Post-Procedure Assessment

  • Post-procedure IVUS confirms optimal procedural endpoints and identifies complications requiring correction 1

  • Key complications to identify include:

    • Stent underexpansion, deformation, and malapposition 1
    • Edge dissection, hematoma, and tissue protrusion 1
    • Geographic miss and inflow/outflow disease 1
  • Minor edge dissections limited to the intima, involving <45° circumference, and measuring <2mm in length typically don't require correction 1

  • Larger dissections with significant residual plaque burden, extensive lateral (>60°) and longitudinal (>2mm) extension, involvement of deeper layers, or located distal to the stent require intervention 1

Special Considerations for Complex Lesions

  • Left main interventions: IVUS is particularly important with specific cut-off values (distal LM >7-9mm² and proximal LM >8-10mm² in different populations) 1, 2
  • Chronic total occlusions (CTOs): IVUS helps resolve proximal cap ambiguity, delineate cap morphology, and guide true-lumen wiring 1, 2
  • Bifurcation lesions: IVUS aids in determining optimal stenting strategy and proper stent sizing in tapering vessels 1, 2
  • Calcified lesions: IVUS guides appropriate lesion preparation strategies before stent deployment 1, 2

Clinical Benefits of IVUS-Guided PCI

  • Compared to angiography-guided PCI, IVUS guidance is associated with:
    • Reduced risk of cardiovascular death (RR 0.63; 95% CI, 0.54-0.73) 3
    • Lower rates of myocardial infarction (RR 0.71; 95% CI, 0.58-0.86) 3
    • Decreased need for target lesion revascularization (RR 0.81; 95% CI, 0.70-0.94) 3
    • Reduced stent thrombosis (RR 0.57; 95% CI, 0.41-0.79) 3

Common Pitfalls and Caveats

  • Despite proven benefits, IVUS is used in <15% of all PCI procedures due to unfamiliarity with equipment, knowledge gaps in interpretation, perception of increased procedural times, and reimbursement concerns 1
  • IVUS should be used cautiously in spontaneous coronary artery dissection due to risks of manipulating the dissected artery 1
  • Air bubbles between the catheter sheath and IVUS transducer can degrade image quality in mechanical (but not solid-state) catheters 1
  • Stent malapposition should be distinguished from stent underexpansion, as most acute malapposition resolves over time without affecting long-term stent failure rates (unless underexpansion is present) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.